XML 108 R86.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Jul. 28, 2022
Feb. 01, 2021
Jan. 14, 2021
Jul. 02, 2020
Feb. 18, 2020
Dec. 31, 2020
Dec. 31, 2022
Oct. 14, 2022
Dec. 31, 2021
Jul. 07, 2020
Sale of Stock [Line Items]                    
Conversion of convertible preferred stock to common stock upon closing of Initial Public Offering (IPO) (in shares)       31,557,107   31,557,107        
Common stock, authorized (in shares)             200,000,000   200,000,000 200,000,000
Common stock, par value (usd per share)             $ 0.00001   $ 0.00001 $ 0.00001
Preferred stock, authorized (in shares)             10,000,000   10,000,000 10,000,000
Preferred stock, par value (usd per share)             $ 0.00001   $ 0.00001 $ 0.00001
Preferred stock, shares issued (in shares)             0   0  
Preferred stock, shares outstanding (in shares)             0   0  
Omnibus Agreement                    
Sale of Stock [Line Items]                    
Class of warrant issued of common stock (in shares)               3,352,025    
Exercise price (usd per share)               $ 0.01    
The Lemonade Foundation | Affiliated entity                    
Sale of Stock [Line Items]                    
Contribution to the Lemonade Foundation (in shares)         500,000 500,000        
Metromile                    
Sale of Stock [Line Items]                    
Shares issued for acquisition (in shares) 6,901,934                  
IPO                    
Sale of Stock [Line Items]                    
Common stock sold (in shares)       12,650,000            
Common stock sold, price (usd per share)       $ 29            
Net proceeds from sale       $ 335.6            
Offering costs, expensed           $ 3.5        
Underwriter's option                    
Sale of Stock [Line Items]                    
Common stock sold (in shares)   718,647   1,650,000            
Net proceeds from sale   $ 114.6                
Follow On Offering                    
Sale of Stock [Line Items]                    
Common stock sold (in shares)     3,300,000              
Net proceeds from sale     $ 525.7              
Follow On Offering, Selling Shareholders                    
Sale of Stock [Line Items]                    
Common stock sold (in shares)     1,524,314              
Follow On Offering, Selling Shareholders | The Lemonade Foundation                    
Sale of Stock [Line Items]                    
Common stock sold (in shares)     100,000